Small Cell Lung Carcinoma Clinical Trials

109 clinical trials for Small Cell Lung Carcinoma across international registries, including 24 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 — RECRUITING · PHASE1
• Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial) — RECRUITING · PHASE1
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — RECRUITING · PHASE1
• Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors — RECRUITING · PHASE1
• DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers — RECRUITING · PHASE2
• A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of LY4175408 in Participants With Advanced Cancer — RECRUITING · PHASE1
• A Study of Hospital-at-Home for People Receiving Tarlatamab — RECRUITING · NA
• A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain — RECRUITING · PHASE2
• A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer — RECRUITING · PHASE1
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients — RECRUITING · NA
• Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial — RECRUITING · PHASE3
• Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer — RECRUITING · PHASE1
• Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients — RECRUITING · NA
• Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer — RECRUITING · PHASE2
• Biology of Young Lung Cancer Study: The YOUNG LUNG Study — RECRUITING
• Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer — RECRUITING · NA
• Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors — RECRUITING · PHASE1
• Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC) — RECRUITING · PHASE2
• Molecular Analysis and Treatment Options of SCLC — RECRUITING
• PET-guided Radiotherapy for Patients With Small Cell Lung Cancer. — RECRUITING
• A Phase IIII Study of AL8326 in Small Cell Lung Cancer — RECRUITING · PHASE3
• A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC — RECRUITING · PHASE2
• A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 — ACTIVE_NOT_RECRUITING · PHASE1
• DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE1
• Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer — TERMINATED · PHASE2
• Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer. — ACTIVE_NOT_RECRUITING · PHASE3
• ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers — TERMINATED · PHASE1
• DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) — NOT_YET_RECRUITING · PHASE1
• An Exploratory Study of Lurbinectedin With Radiotherapy in SCLC With Single-lesion Progression After First Course Treatment — ACTIVE_NOT_RECRUITING · PHASE2
• A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer. — ACTIVE_NOT_RECRUITING
• A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. — NOT_YET_RECRUITING · PHASE2
• Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98) — ACTIVE_NOT_RECRUITING · PHASE1
• Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer — COMPLETED · PHASE1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors — COMPLETED · PHASE1
• Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax — ACTIVE_NOT_RECRUITING · PHASE2
• Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD — NOT_YET_RECRUITING · PHASE2
• Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC) — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants. — COMPLETED · PHASE1
• A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors — TERMINATED · PHASE1
• Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) — ACTIVE_NOT_RECRUITING · PHASE2
• Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008) — ACTIVE_NOT_RECRUITING · PHASE3
• REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER — COMPLETED
• Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · NA
• Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. — COMPLETED · PHASE1
• Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers — COMPLETED · PHASE1

Refine this search